 SAN DIEGO, June 2, 2021 PRNewswire -- Kintara Therapeutics, Inc. Nasdaq: KTRA, a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced today that Chief Executive Officer Saiid Zarrabian will present a corporate overview at the three-day LD Micro Virtual Invitational Conference being held on June 8 10, 2021. Mr. Zarrabian will deliver his corporate presentation on June 9 at 2:30 pm ET, Track 1. 